CLCN1 Antibody

說明書

中文名稱：

CLCN1兔多克隆抗體
貨號：

CSB-PA005480
規(guī)格：

￥2024
圖片：
Western blot analysis of extracts of various cell lines, using CLCN1 antibody.
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) CLCN1 Polyclonal antibody
Uniprot No.：

P35523
基因名：

CLCN1
別名：

Chloride channel protein 1 antibody; Chloride channel protein antibody; Chloride channel protein skeletal muscle antibody; CIC 1 antibody; CIC1 antibody; ClC-1 antibody; CLC1 antibody; Clcn1 antibody; CLCN1_HUMAN antibody; MGC138361 antibody; MGC142055 antibody; skeletal muscle antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant protein of Human CLCN1.
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

Antibodies were purified by affinity purification using immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
產(chǎn)品提供形式：

Liquid
應用范圍：

WB

推薦稀釋比：

Application	Recommended Dilution
Westernblotting	1:500~1:2000

Protocols：

Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Voltage-gated chloride channel. Plays an important role in membrane repolarization in skeletal muscle cells after muscle contraction. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The absence of conserved gating glutamate residues is typical for family members that function as channels.
基因功能參考文獻：
1. The novel missense CLCN1 mutations is associated with a family affected with myotonia congenital. PMID: 29896741
2. Loss-of- function mutations in the CLCN1 gene located on 7q35, are the primary contributors to the pathogenesis of Thomsen myotonia PMID: 27639085
3. Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90beta as a molecular model for myotonia congenita has been described. PMID: 27580824
4. the spectrum of CLCN1 mutations in patients with Myotonia Congenita PMID: 28427807
5. Combining our results with the literature on Chinese populations indicates that 21 mutations in CLCN1 have been associated with myotonia congenital, while 7 mutations in SCN4A have been associated with paramyotonia congenita, 2 mutations in SCN4A have been associated with sodium channel myotonias. PMID: 27415035
6. report a novel ClC-1 mutation, T335N, that is associated with a mild phenotype PMID: 27324117
7. The present study is the first demonstration of ClC-1 regulation in active human muscle, and it provides a detailed description of the involvement of PKC and ClC-1 in the down-regulation of Gm during AP-firing activity in human skeletal muscle fibres PMID: 26857341
8. This study, novel mutations in CLCN1 were detected, and the spectrum of CLCN1 mutations known to be associated with MC was expanded. PMID: 27118449
9. our study confirms the presence of the myotonia causing CLCN1 mutations p.F167L and p.R105C in the Costa Rican population. PMID: 26510092
10. Three novel mutations including 2 missense and one splicing were found in myotonia congenita patients. PMID: 26260254
11. we characterized three other myotonic ClC-1 mutations. PMID: 26096614
12. In 4 patients (3 families) with recessive MC, 4 CLCN1 variants were found, 3 of which are new. c.244A>G (p.T82A) and c.1357C>T (p.R453W) were compound heterozygotes with c.568GG>TC (p.G190S). The new c.809G>T (p.G270V) was homozygous. PMID: 26007199
13. Our data are consistent with the idea that the CUL4A/B-DDB1-CRBN complex catalyses the polyubiquitination and thus controls the degradation of CLC-1 channels. PMID: 26021757
14. investigated sequences of PRRT2 and CLCN1 in a proband diagnosed with paroxysmal kinesigenic dyskinesia and suspected myotonia congenita; the proband and his father harbored a PRRT2 c.649dupC mutation, and CLCN1 c.1723C>T and c.2492A>G mutations; first report showing the coexistence of PRRT2 and CLCN1 mutations PMID: 25205014
15. This electrophysiological and clinical observations suggest that heterozygous CLCN1 mutations can modify the clinical and electrophysiological expression of SCN4A mutation. PMID: 25088311
16. splicing mutations accounted for 23 percent of all pathogenic variants in the cohort of myotonia congenita patients; 4 were heterozygous mutations in 4 unrelated individuals: c.563G>T in exon 5; c.1169-5T>G in intron 10; c.1251+1G>A in intron 11 and c.1931-2A>G in intron 16 PMID: 24452722
17. Six mutant forms of human CLC1 demonstrate modifications of channel gating behaviors and reduced chloride conductances that likely contribute to the physiologic changes of myotonia congenita. PMID: 24625573
18. in Czech patients with myotonia congenita(MC), 34 differentCLCN1 mutations were identified in 51 MC probands (14 new mutations); structural analysis of mutations in the homology model of the dimeric ClC-1 protein was performed; results demonstrate structure-function relationships in the ClC-1 protein which are relevant to understanding the molecular pathogenesis of MC PMID: 24349310
19. Early truncating mutations of CLCN1 precluding dimerization are expected to express an autosomal recessive phenotype in patients with myotonia congenita. PMID: 23893571
20. The common CIC-1 gate likely occludes the channel pore via interaction of E232 with a highly conserved tyrosine, Y578, at the central anion-binding site. PMID: 24064982
21. Two mutations in CN1 gene, inherited on the same allele as a heterozygous trait, abrogate disease expression, although when inherited singularly they were pathogenic. PMID: 23739125
22. family reveals that compound heterozygosity of two dominantly inheritable disease mutations exacerbates the myotonia, suggesting the dosage effect of CLCN1 mutation responsible for myotonia congenita of Thomsen type. PMID: 23603549
23. patients with myotonia congenita with very different phenotypes depending on mutation of ClC-1. PMID: 23933576
24. Non-dystrophic myotonias are characterised by muscle stiffness during voluntary movement owing to delayed skeletal muscle relaxation caused by mutation in the CLCN1 skeletal muscle channel genes. PMID: 23417379
25. Genetic testing in both patients reveals previously unidentified mutations in the CLCN1 gene specific to Myotonia Congenita PMID: 23483815
26. Non-dystrophic myotonias are rare diseases caused by mutations in skeletal muscle CLCN1. PMID: 23771340
27. functional and biochemical characterization of a myotonia mutation PMID: 23424641
28. Our findings predict a dramatic reduction of the muscle fibre resting chloride conductance and thus fully explain the disease-causing effects of mutations C277R and C277Y of CLC1 in myotonia congenita PMID: 22641783
29. The co-segregation of Myotonic dystrophy type 2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings for juvenile onset of myotonia in a 14-year-old female with Myotonic dystrophy type 2 and her affected mother PMID: 22407275
30. Molecular localization reveals the presence of CLCN1 mRNA transcripts in brain, previously believed absent in neurons. PMID: 23408874
31. A single heterozygous missense CLCLN1 mutation, G233S, was associated with autosomal dominant myotonia congenita in a father & son.It affected the fast gate but not the common gate. PMID: 22790975
32. CLCN1 mutations may cause a decrease in macroscopic chloride currents, impairing membrane potential repolarization and causing hyperexcitability in muscle membranes. PMID: 22521272
33. ClC1 mutations exert gene dose effects and enhance myotonia and pain in DM2 in Germany. Additionally, the ClC1(236X) splice variant may contribute to myotonia in DM2. PMID: 23097607
34. The spectrum of CLCN1 gene mutations in patients with nondystrophic Thomsen's and Becker's myotonias in Russia. PMID: 23113340
35. Identification of new mutations leads to reclassification of Trp-118-Gly in CLCN1 as a moderately pathogenic mutation, and to confirmation of recessive (Becker) myotonia congenita. PMID: 23152584
36. study describes a large Brazilian consanguineous kindred with 3 clinically affected patients with a Thomsen myotonia phenotype; they carry a novel homozygous nonsense mutation in the CLCN1 gene (K248X); none of the 6 heterozygote carriers show any sign of myotonia PMID: 22246887
37. a new biological role for NAD suggests that the main physiological relevance may be the exquisite sensitivity to intracellular pH that NAD(+) inhibition imparts to ClC-1 gating. PMID: 22689570
38. copy number variation in CLCN1 may be an important cause of recessive myotonia congenita. PMID: 22649220
39. This study demonistrated that 26 different mutations in CLCN1 gene including 13 not reported previously. Among those 26 mutations, c.180+3A>T in intron 1 is present in nearly one half of the Spanish families in this series. PMID: 22094069
40. Elucidating the pathophysiology of myotonia mutations will require the understanding of multiple molecular/cellular mechanisms of CLC-1 channels in skeletal muscles, including molecular operation, protein synthesis, and membrane trafficking mechanisms. PMID: 22187529
41. Mutations in CLCN1 contributes to the pronounced variability in the myotonic phenotype. PMID: 21204798
42. Identified a novel p.N440K sodium channel mutation that is located at the inner end of segment S6 of repeat I. PMID: 22106717
43. Our data showed that slow activation gating of P480T ClC-1 mutation impaired the increment of chloride conductance during repetitive depolarization PMID: 21385601
44. sequencing of CLCN1 gene in 2 families with myotonia congenita revealed heterozygous mutation (892G>A, resulting in A298T) in 1 family and compound heterozygous mutations (782A>G, resulting in Y261C;1679T>C, resulting in M560T)in the other family PMID: 21045501
45. Closure of the common gate in ClC-1 channels is accompanied by a separation of the carboxyl-termini, whereas, with opening, the carboxyl-termini approach each other more closely. PMID: 21413926
46. A novel p.L2871 mutation in the CLCN1 gene is described in a Honduran boy with myotonia congenita; his unaffected father carries the same mutation, most likely reflecting autosomal-recessive myotonia congenita. PMID: 20399394
47. hClC-1 mutants expressed in whole-cell patch-clamped HEK293 cells showed that elimination of the carboxyl side chain in the E232Q mutation prevents fast gate closure at all voltages but common gating is also eliminated. PMID: 20398785
48. A novel mutation, 568GG>TC(G190S) in the CLCN1 gene, is responsible for autosomal dominant myotonia congenita with a variable phenotypic spectrum. PMID: 19697366
49. We investigated a 62-year-old man who had mild clinical features of myotonia congenita. He was found to have a novel heterozygous G-to-A nucleotide substitution at position 1652 in exon 15 of the CLCN1 gene. PMID: 20120005
50. CLCN1 dysfunction alone does not result in skeletal muscle morphologic changes even in advanced stages of myotonia congenita, and MRI skeletal muscle alterations in myotonic dystrophy must be clear consequences of the dystrophic disease process PMID: 20047568
顯示更多

收起更多
相關疾?。?/div>
Myotonia congenita, autosomal dominant (MCAD); Myotonia congenita, autosomal recessive (MCAR)
亞細胞定位：

Cell membrane; Multi-pass membrane protein.
蛋白家族：

Chloride channel (TC 2.A.49) family, ClC-1/CLCN1 subfamily
組織特異性：

Predominantly expressed in skeletal muscles.
數(shù)據(jù)庫鏈接：

HGNC: 2019

OMIM: 118425

KEGG: hsa:1180

STRING: 9606.ENSP00000339867

UniGene: Hs.121483

Most popular with customers

YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human